Use of myeloid growth factors for patients with febrile neutropenia: plus ca change, plus c'est la même chose.
Schiffer
Charles A
CA
Division of Hematology/Oncology, Karmanos Cancer Institute, Wayne State University School of Medicine, 4100 John R, HWCRC 4th Floor, Detroit, MI, USA.
D002648:Child; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D005334:Fever / Q000188:drug therapy* / Q000209:etiology; D016179:Granulocyte Colony-Stimulating Factor / Q000191:economics* / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000150:complications; D009503:Neutropenia / Q000188:drug therapy* / Q000209:etiology; D014481:United States
D016179:Granulocyte Colony-Stimulating Factor